Literature DB >> 1450655

Laser treatment of diffuse retinal pigment epitheliopathy.

L A Yannuzzi1, J S Slakter, S R Kaufman, K Gupta.   

Abstract

The Authors report laser treatment of 18 eyes (14 patients) with a variant of central serous chorioretinopathy associated with widespread decompensation of the retinal pigment epithelium (RPE) in the macula, diffuse retinal pigment epitheliopathy (DRPE). All eighteen eyes with DRPE were treated with Krypton red laser photocoagulation in a grid pattern to leaking RPE in areas of neurosensory retinal detachment. All eyes showed anatomic improvement with resolution of the serous macular detachment and lipid exudation. The visual acuity was stabilized in 15 eyes (83%) at 6 months' follow-up, but only 3 eyes (17%) demonstrated improved visual acuity in the same time interval. At eighteen months, 2 of 15 eyes (13%) retained improved visual acuity, 11 eyes (74%) remained unchanged, and 2 eyes (13%) had visual loss. In this series of patients with DRPE, grid laser photocoagulation treatment was uniformly successful in producing an anatomic improvement in the exudative manifestations of the macula and in preventing or slowing progression of vision loss.

Entities:  

Mesh:

Year:  1992        PMID: 1450655     DOI: 10.1177/112067219200200301

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   1.922


  21 in total

1.  [Inferior retinal detachment with whitish subretinal lesion].

Authors:  H Helbig; C Valmaggia; H Niederberger
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

Review 2.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

3.  [Selective retina therapy in central serous chorioretinopathy with detachment of the pigmentary epithelium].

Authors:  C Klatt; H Elsner; E Pörksen; R Brinkmann; A Bunse; R Birngruber; J Roider
Journal:  Ophthalmologe       Date:  2006-10       Impact factor: 1.059

4.  Familial central serous retinopathy.

Authors:  J A Oosterhuis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-05       Impact factor: 3.117

5.  Retinal neovascularization in a patient with chronic central serous chorioretinopathy.

Authors:  Vinod K Aggarwal; Pulak Agarwal; Shoryavardhan Azad
Journal:  Indian J Ophthalmol       Date:  2020-08       Impact factor: 1.848

6.  Retinal thickness changes following photodynamic therapy in chronic central serous chorioretinopathy.

Authors:  Sergio Copete; Jose M Ruiz-Moreno; Carlos Cava; Javier A Montero
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-06       Impact factor: 3.117

7.  Clinical characteristics of polypoidal choroidal vasculopathy associated with chronic central serous chorioretionopathy.

Authors:  Han Sang Park; In Taek Kim
Journal:  Korean J Ophthalmol       Date:  2012-01-14

8.  One-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy: the outer nuclear layer thickness is associated with visual prognosis.

Authors:  Yasuhiro Ohkuma; Takaaki Hayashi; Tsutomu Sakai; Akira Watanabe; Hiroshi Tsuneoka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-02       Impact factor: 3.117

9.  Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.

Authors:  W-M Chan; D S C Lam; T Y Y Lai; B S M Tam; D T L Liu; C K M Chan
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

10.  Prognostic factors related to photodynamic therapy for central serous chorioretinopathy.

Authors:  Jun Woong Moon; Hyeong Gon Yu; Tae Wan Kim; Hyung Chan Kim; Hum Chung
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-07       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.